Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Diffuse Mixed Small and Large Cell Lymphoma

fluorodeoxyglucose f18 has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 461 studies

Research

Studies (461)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.22)	18.7374
1990's	41 (8.89)	18.2507
2000's	197 (42.73)	29.6817
2010's	176 (38.18)	24.3611
2020's	46 (9.98)	2.80

Authors

Authors	Studies
Fujimoto, S; Ishishita, Y; Kawai, K; Koide, R; Mashiko, T; Matsuzono, K; Ohtani, K; Ozawa, T; Tanaka, R; Yagisawa, T; Yamaguchi, T	1
Cheson, BD; Meignan, M	1
Wu, Y; Xiang, XR; Yang, CL	1
Du, B; Hao, W; Li, X; Li, Y	1
Bailly, C; Bodet-Milin, C; Carlier, T; Gastinne, T; Kraeber-Bodere, F; Le Gouill, S; Tessoulin, B	1
Li, J; Liu, Y; Ma, N; Yuan, L; Zhao, M	1
Ansell, SM; Bansal, R; Bennani, NN; Breen, WG; Hathcock, MA; Johnston, PB; Khurana, A; Kowalchuk, RO; Lester, SC; Lin, Y; Paludo, J; Peterson, JL; Villasboas Bisneto, JC; Wang, Y; Young, JR	1
Akashi, K; Baba, S; Iawasaki, H; Ishigami, K; Kamesaki, K; Kato, K; Kikushige, Y; Kunisaki, Y; Miyamoto, T; Miyawaki, K; Mori, Y; Numata, A; Shima, T; Sugio, T; Takashima, S; Takenaka, K; Urata, S; Yoshimoto, G	1
Albader, FL; Elhaggracy, RS; Marafi, F; Usmani, S	1
Choi, JY; Kim, SJ; Lee, KH; Yi, HK; Yoo, J	1
Kang, HJ; Lee, I; Lee, KC; Lim, I; Lim, SM	1
Dührsen, U; Fendler, WP; Ferdinandus, J; Hanoun, C; Herrmann, K; Hüttmann, A; Kersting, D; Rahbar, K; Reinhardt, HC; Rischpler, C; Sandach, P; Schäfers, M; Seifert, R; Umutlu, L; von Tresckow, B; Weckesser, M	1
Giannakopoulos, V; Ilias, I; Meristoudis, G	1
Chen, YJ; Hsieh, CH; Huang, YM; Lee, JC; Tsao, CH; Wang, SY	1
Shen, K; Yang, C	1
Ansell, SM; Bansal, R; Breen, WG; Hathcock, MA; Hoppe, BS; Iqbal, M; Johnston, PB; Kharfan-Dabaja, MA; Khurana, A; Lester, SC; Lin, Y; Moustafa, MA; Munoz, J; Murthy, HS; Paludo, J; Peterson, JL; Rosenthal, A; Rule, WG; Saifi, O; Stish, BJ; Villasboas, JC; Wang, Y	1
He, Y; Li, P; Li, Y; Yang, J; Zhao, W	1
Dai, N; Deng, S; Han, J; Huang, H; Jia, T; Sang, S; Zhang, B; Zhou, Y	1
Cheng, W; Feng, J; He, D; Qi, S; Xu, C; Yue, Y; Zhang, G	1
Hernández-Cruz, M; López-Colombo, A; Montiel-Jarquín, ÁJ; Ruiz-Eng, R; Vargas-Partida, T; Vázquez-Cruz, E	1
Lijun, Z; Xiao-Xue, W; Xinyue, H	1
Bando, Y; Dimitrakopoulou-Strauss, A; Harada, M; Kondo, M; Kubo, M; Otomi, Y; Otomo, M; Shinya, T; Terazawa, K	1
Amoedo, MK; Barbosa, PNV; Dantas, GC; Travesso, DJ; Tyng, CJ	1
Akin, S; Erbaş, B; Eren, G; Kars, A; Kupik, O; Tuncel, M; Türker, A	1
Alessandrino, F; Kalisz, K; Levine, I; Ramaiya, NH; Smith, DA; Tirumani, SH	1
Amarelli, C; Belfiore, MP; Cappabianca, S; Casale, B; Ciccozzi, M; Creta, M; DE Rimini, ML; Maiello, C; Reginelli, A; Sagnelli, C; Sagnelli, E; Sica, A; Spada, A; Troiani, T	1
Cheong, JW; Cho, A; Cho, H; Chung, H; Jang, JE; Kim, JS; Kim, SJ; Kim, Y; Kim, YR; Min, YH; Yang, WI	1
Gallamini, A; Meignan, M	1
Kuang, A; Shen, G	1
Gupta, T; Kannan, S; Manjali, JJ; Purandare, N; Rangarajan, V	2
Li, F; Luo, Y; Pan, Q; Zhang, Y	1
González, E; Martí, A; Morón, S; Rojas, J	1
Blakkisrud, J; Dahle, J; Kolstad, A; Løndalen, A; Madsbu, UE; Revheim, ME; Stokke, C	1
Ge, Y; He, J; Ji, CF; Liu, S; Sun, YW; Wang, H; Zhou, ZY	1
Fan, W; Yuan, J; Zhang, X; Zhou, C	1
Carpenter, B; Castleton, A; Elliot, J; Fielding, AK; Fox, TA; Grandage, V; Halsey, R; Hough, R; Khwaja, A; Mansour, MR; Nicholson, E; Perisoglou, M; Taj, M; Uttenthal, B; Wright, C	1
Bektaş, S; Beyhan, E; Çermik, TF; Ergül, N; Erol, Ö	1
Chen, Y; Tang, W; Wang, Q; Yang, S	1
Bernard, S; Guevara, DL; Manhood, S; Melani, S; Rodríguez, MLÁ; Yerovi, F	1
Choi, JY; Hyun, SH; Kim, SJ; Kim, WS; Lee, JH; Lee, KH; Min, BH; Moon, SH; Park, YJ	1
Altmann, B; Angel, S; Barbato, F; Bewarder, M; Dührsen, U; Grosse, J; Held, G; Hellwig, D; Herrmann, K; Hüttmann, A; Kaddu-Mulindwa, D; Löffler, M; Menhart, K; Pfreundschuh, M; Poeschel, V; Schwier, M; Stilgenbauer, S; Thurner, L; Ziepert, M	1
Francis, JH; Grommes, C; Hatzoglou, V; Krebs, S; Mauguen, A; Mellinghoff, IK; Schaff, LR; Schöder, H; Yildirim, O	1
Baraniskin, A; Frey, AV; Herrlinger, U; Korfel, A; Kowalski, T; Ladigan-Badura, S; Margold, M; Schlegel, U; Schmidt-Wolf, IGH; Schroers, R; Seidel, S	1
Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Goldman, A; Iyengar, S; Kowa, JY; Li, S; Mackinnon, A; Mahalingam, P; Marshall, K; Millard, T; Nicholson, E; Rich, P; Sharma, B; Sharma, RK; Welsh, L	1
Fujimoto, K; Hoshikawa, H; Ihara-Nishishita, A; Kobata, T; Kudomi, N; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y	1
A-Risheq, MZ; Alhouri, A; Juweid, ME; Mottaghy, FM; Mueller, M	1
Castro, AC; Mamede, M; Paulino, E; Ribeiro, TH; S, R	1
Abramson, JS; Advani, R; Ansell, S; Aurer, I; Bollard, C; Coiffier, B; de Vos, S; Dreyling, M; Elsayed, YA; Engert, A; Federico, M; Fisher, RI; Fortpied, C; Fowler, N; Gopal, A; Goy, A; Gribben, J; Hagenbeek, A; Hilden, P; Hutchings, M; Kaminski, MS; Kelly, K; Kloos, I; Kuruvilla, J; Leonard, JP; Little, RF; Meignan, M; Morschhauser, F; Pfreunschuh, M; Rademaker, J; Rule, S; Salles, G; Schoder, H; Schuster, SJ; Schwartz, LH; Sehn, LH; Seshan, VE; Seymour, JF; Smith, M; Takeshita, K; Thieblemont, C; Tobinai, K; Trneny, M; Valente, N; Van Oers, MHJ; Wilson, W; Witzig, TE; Younes, A; Zelenetz, AD; Zinzani, PL	1
Barrington, SF; Kluge, R	1
Kjaergaard, T; Petersen, KB	1
Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N	1
Byun, JM; Heo, DS; Jeon, YK; Kim, KH; Kim, M; Kim, TM; Lee, HY; Lee, JM; Lee, JO; Lee, JS; Paik, JH; Park, JH	1
Laffon, E; Marthan, R	1
Choi, W; D'Souza, WD; Kang, MK; Li, L; Lu, W; Tan, S	1
Bairey, O; Berger, T; Cohen, YC; Eshel, L; Raanani, P; Shpilberg, O; Stern, D	1
Barrington, SF; Johnson, PWM	1
Barrington, S; Hasenclever, D; Kluge, R; Kurch, L	1
Chakfé, N; Lejay, A	1
Giraudo, C; Jaeger, U; Karanikas, G; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Dickson, JC; Haryee, H; Miller, RF; Vora, N	1
Basher, RK; Das, A; Kalra, N; Malhotra, P; Mittal, BR; Prakash, G; Radhakrishnan, RK	1
Jiang, W; Wang, Q; Wang, Z; Xue, H; Zhang, X; Zhao, C	1
Chen, S; Fu, H; He, K; Ma, C; Wang, H; Wang, S	1
Fukunaga, H; Mutoh, T; Nakagawa, M; Shimomura, H; Taki, Y; Tatewaki, Y; Terao, C; Totsune, T; Yamamoto, S	1
Bechter, O; De Keyzer, F; De Paepe, KN; Dierickx, D; Janssens, A; Oyen, R; Vandecaveye, V; Verhoef, G; Wolter, P	1
Kuo, DJ; Paul, MR	1
Abadi-Korek, I; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Nidam, M; Shpilberg, O	1
Fujii, H; Harata, N; Isogai, J; Nomoto, Y; Oota, S; Tanaka, H; Yoshida, K	1
Behringer, D; Bengel, FM; Berdel, WE; Bernhard, H; Bockisch, A; Brink, I; Brinkmann, M; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Gaska, T; Geworski, L; Giagounidis, A; Griesshammer, M; Haberkorn, U; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Kofahl-Krause, D; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Maschmeyer, G; Matschke, J; Mesters, R; Müller, S; Ose, C; Pöppel, T; Prange-Krex, G; Raghavachar, A; Rekowski, J; Scherag, A; Schmitz, C; Thomssen, H; van Assema, DME; Weckesser, M; Wilop, S	1
Hussey, D; Maganti, M; Metser, U; Parvez, A; Tau, N	1
Enqvist, O; Lind, E; Polymeri, E; Sadik, M; Trägårdh, E; Ulén, J	1
Bashir, H; Hassan, A; Niazi, IK; Razi, M	1
Badr, S; Elahmadawy, MA; Kotb, M; Moustafa, H	1
Alfageme, F; Catalano, O; Koppula, V; Mandava, A; Wortsman, X	1
Abebe-Campino, G; Ben-Haim, S; Davidson, T; Hoffmann, C; Shrot, S; Toren, A	1
Chang, AH; Chen, D; Hu, Y; Huang, H; Wang, J; Wei, G; Wu, W; Wu, Z; Xiao, L; Yang, S; Zhang, Y; Zhao, K; Zhao, X	1
Lim, K; Maingard, J; Nambiar, M; Tai, R	1
Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S	1
Anconina, R; Hod, N; Lantsberg, S; Levi, I; Levin, D; Nalbandyan, K	1
Galal, A; Wang, J	1
Anker, MS; Finke, D; Haberkorn, U; Heckmann, MB; Katus, HA; Lehmann, LH; Müller-Tidow, C; Totakhel, B	1
Choi, CW; Choi, TH; Hwang, JP; Kang, HJ; Kim, BI; Kim, KM; Lee, SS; Lim, I; Lim, SM; Park, JY; Yang, SH	1
Sioka, C	1
George, A; Hicks, RJ; Hofman, MS; Kashyap, R; Lade, S; Lau, E; Seymour, JF	1
Araf, S; Montoto, S	1
Takei, T; Uchiyama, M	1
Karanikas, G; Raderer, M; Toth, DF; Wadsak, W	1
Amthauer, H; Erdrich, AS; Furth, C; Grandt, R; Hauptmann, K; Hautzel, H; Hundsdoerfer, P; Kahraman, D; Kobe, C; Ruf, J; Schönberger, S; Steffen, IG; Stiebler, M	1
Guo, N; Li, JM; Li, XY; Zhu, HM	1
Chen, Y; Li, C; Li, F; Shen, Z; Tian, J; Wang, R; Xu, B; Yu, L; Zhu, H	1
Cui, Y; Dong, A; Gao, L; Wang, Y; Yang, J; Zuo, C	1
Dong, A; Wang, Y; Zhao, T; Zuo, C	1
Huang, G; Lu, J; Song, S; Wei, X; Zhu, Y	1
Eom, HS; Kang, SH; Kim, SK; Kim, TS; Kim, YI; Lee, H; Park, WS; Yun, T	1
Beppu, K; Himeji, D; Kawano, N; Kuriyama, T; Masuyama, H; Ono, N; Oshima, K; Oyama, M; Shimao, Y; Ueda, A; Ueda, Y; Yamaguchi, K; Yamashita, K; Yoshida, S	1
Cai, L; Fu, D; Fu, W; Gui, S; Li, J; Li, W; Lu, B; Tang, R; Yang, P; Zhang, H	1
Barker, C; Goenka, A; Gonen, M; Kowalski, A; Lim, R; Lovie, S; McCann, P; Schöder, H; Terezakis, SA; Turlakov, A; Yahalom, J	1
Canbaz Tosun, F; Cıraklı, A; Cıraklı, S; Dabak, N; Dağdemir, A; Elli, M	1
Hussey, D; Metser, U; Murphy, G	1
Macdonald, WB; McQuillan, AD; Turner, JH	1
Barrington, SF; Cavalli, F; Cheson, BD; Fisher, RI; Lister, TA; Schwartz, LH; Zucca, E	1
Heo, NY; Joo, YD; Kim, IH; Kim, JY; Kim, SH; Lee, SI; Park, JI; Park, SH; Shim, HK	1
Bachmann, KR; Foster, WC; Fox, MG; LeGallo, RD; Marti, JK	1
Bai, X; Chen, L; Gao, J; Hu, H; Nie, Y; Niu, X; Xu, H; Zhao, W	1
Bachanova, V; Burns, LJ; Cao, Q; Froelich, J; Kendi, AT; Lazaryan, A; Ustun, C	1
Bhojwani, D; Choi, JK; Davidoff, AM; Gold, R; Inaba, H; McCarville, MB; Metzger, ML; Sandlund, JT; Sawyer, J; Shulkin, BL	1
Luminari, S; Trotman, J	1
Marina, V; Milena, R; Slađana, P; Vera, A; Vesna, P	1
Antonelli, A; Grosso, M; Guidoccio, F	1
Cui, Y; Fan, Y; Fu, Z; Jiang, Q; Kang, L; Liao, X; Liu, M; Wang, R; Wang, Y; Zhang, J; Zhang, X	1
Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA	2
Carrió, I; Domenech, A; Escalera, S; Sampedro, F	1
Dominguez, ML; Garcia, L; Infante, JR; Moreno, M; Rayo, JI; Serrano, J	1
El-Galaly, TC; Hutchings, M	1
Adams, HJ; Kwee, TC	2
Bennani-Baiti, B; Bennani-Baiti, N; Flynt, L; Yadav, S	1
Dolak, W; Jaeger, U; Karanikas, G; Kiesewetter, B; Kletter, K; Knogler, T; Lukas, J; Mayerhoefer, ME; Müllauer, L; Porpaczy, E; Prosch, H; Raderer, M; Sillaber, C; Simonitsch-Klupp, I; Skrabs, C; Ubl, P; Weber, M	1
Ağlarcı, OS; Aral, CA; Hatipoğlu, F; Karaarslan, S; Sanal, MS; Taşlı, F; Yılmaz, HH	1
Carlos Herrera, J; Chen-Liang, TH; Contreras, J; Cozar, Mdel P; Fernandez-Gonzalez, M; Fernandez-Muñoz, H; Frutos, L; Igua, C; Jerez, A; Lancharro, A; Luis Navarro, J; Martin-Santos, T; Muiña, B; Orero, MT; Ortuño, FJ; Perez-Ceballos, E; Raya, JM; Remigia, MJ; Romera, M; Sanchez-Blanco, JJ; Sanchez-Vaño, R; Senent, L; Uña, J; Villegas, C	1
Dai, Y; Sowjanya, M; Xu, K; You, J	1
Agura, E; Ahn, KW; Akpek, G; Armand, P; Bachanova, V; Burns, LJ; Cairo, MS; Carreras, J; Cashen, AF; Cohen, JB; D'Souza, A; Freytes, CO; Gale, RP; Ganguly, S; Ghosh, N; Hamadani, M; Holmberg, LA; Inwards, DJ; Jaglowski, SM; Kanate, AS; Kharfan-Dabaja, MA; Laport, GG; Lazarus, HM; Malone, AK; Maloney, DG; Munker, R; Mussetti, A; Nishihori, T; Norkin, M; Prestidge, TD; Rowe, JM; Satwani, P; Siddiqi, T; Smith, SM; Stiff, PJ; Sureda, AM; William, BM; Wirk, B	1
Goldman, DA; Gönen, M; Lilienstein, J; Migliacci, J; Moskowitz, CH; Sauter, CS; Schöder, H; Ulaner, GA; Zelenetz, AD	1
Hwang, GY; Leung, GK; Li, LF; Lui, WM; Pu, JK; Taw, BB	1
Ahlström, H; Molin, D; Mosavi, F; Selling, J; Wassberg, C	1
Aide, N; Binns, D; Bourhis, D; Callahan, J; Desmonts, C; Hicks, RJ; Hofman, MS; Le Roux, PY; Quak, E; Robin, P; Salaun, PY	1
Bongioanni, F; Buschiazzo, A; Capitanio, S; De Astis, E; De Carli, F; Fiz, F; Marini, C; Miglino, M; Morbelli, S; Pomposelli, E; Sambuceti, G; Verardi, MT	1
English, JF; Sullivan, TJ	1
Tang, HJ	1
Asabella, AN; Brunese, L; Calabrese, A; de Fazio, V; De Tullio, G; Ferrari, C; Ficco, M; Guarini, A; Loseto, G; Maggialetti, N; Minoia, C; Rubini, G	1
Chen, G; Chen, S; Jiang, L; Li, Y; Shi, H	1
Degrieck, B; Goethals, I; Gykiere, P; Jans, L	1
Marcus, C; Nunna, P; Subramaniam, RM; Taghipour, M	1
De Renzo, A; Del Vecchio, S; Fonti, R; Nicolai, E; Salvatore, B	1
Ardeshna, K; Halsey, R; Kayani, I; Skoura, E; Wan, S	1
Li, P; Liu, Q; Lu, J; Luo, H; Song, S; Wang, C; Wu, S	1
Dolak, W; Giraudo, C; Karanikas, G; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Huang, J; Xie, P	1
Jones, S; Marcus, C; Sarangi, R; Subramaniam, RM; Taghipour, M; Trahan, TJ	1
Agrawal, A; Chandra, P; Purandare, N; Rangarajan, V; Shah, S	1
Abramson, JS; Arabasz, G; Atkinson, W; Barnes, J; Blake, MA; Catalano, O; Catana, C; Guimaraes, AR; Hochberg, E; McDermott, S; Muse, V; Rosen, BR; Shelly, M	1
Hubbard, J; Mohan, H; Moonim, M; Paschali, A	1
Afaq, A; Ardeshna, KM; Babikir, S; Ganeshan, B; Groves, AM; Kayani, I; Miles, KA; Shortman, R	1
Byun, BH; Choi, CW; Hwang, JP; Kim, BI; Lim, I; Lim, SM	1
Chi, KK; Kader, I; Leavers, B; Shashinder, S; Sundaresan, P; Wylie, B	1
Federico, M; Johnson, P; Trotman, J	1
Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S	1
Dai, D; Dong, YW; Fu, Q; Li, XF; Liu, JJ; Song, XY; Xu, WG; Zuo, C	1
Meignan, M	1
Chen, Y; Li, J; Qiu, L; Tu, G	1
Li, D; Qiu, H; Tian, T; Wang, L; Zhang, Q	1
Cousins, J; Currie, G; Czachowski, M; Muthukrishnan, A	1
Baetz, T; Dudebout, J; Hodgson, DC; Langer, DL; MacCrostie, P; Mak, V; Metser, U; Tau, N	1
Biesma, DH; Grutters, JC; Nieuwenhuizen, L; Verzijlbergen, FJ; Wiltink, E	1
Cheson, BD	1
Castellucci, P; Egesta, L; Fanti, S; Golemi, A; Grassetto, G; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Tsamita, CS; Zinzani, PL	1
Ferguson, PJ; Khanna, G; Sato, TS	1
Israel, DA; Souza, FF	1
Chan, VC; Chaudhry, AA; Daw, HA; Farag, HL; Francis, S; Muslimani, AA; Spiro, TP; Taylor, HC	1
Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A	1
Kostakoglu, L	2
Gunawardana, DH; Hicks, RJ; Ho Shon, I; Kirkwood, I; Ramshaw, JE; Robins, P; Scott, AM; Wong, J	1
Daimaru, O; Fukaya, N; Imai, T; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K	1
Ahn, JS; Bom, HS; Cho, SH; Chung, IJ; Jeong, YY; Kim, HJ; Kim, YK; Lee, JJ; Min, JJ; Yang, DH	1
Ambrosini, V; Biassoni, L; Burnelli, R; Castellucci, P; Fanti, S; Lopci, E; Nanni, C; Rubello, D	1
Ambinder, RF; Blackford, AL; Bolaños-Meade, J; Borowitz, MJ; Fidyk, CA; Goodman, SN; Jones, RJ; Kasamon, YL; Rogers, KM; Swinnen, LJ; Wahl, RL; Ziessman, HA	1
Bou-Assaly, W; Broski, SM; Fig, LM; Gross, MD	1
Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Hinterthaner, B; Näke, K; Sabet, A	1
Allen-Auerbach, M; Weber, WA	1
Fukunaga, H; Hatazawa, J; Higuchi, I; Kanakura, Y; Nakamura, H; Sugahara, H; Tatsumi, M	1
Khong, PL; Wong, CY	1
Escalon, MP; Kalkanis, D; Lossos, IS; Paes, F; Serafini, A; Stefanovic, A	1
Aide, N; Hicks, RJ; Irving, L	1
Goda, JS; Keller, H; Lockwood, G; Tsang, R; Vines, DC	1
Dufault, DL; Dunphy, CH; Ivanovic, M; Khandani, AH; Meteesatien, P; Shea, TC	1
Fan, W; Ma, LF	1
Feng, X; Guan, Y; Hua, F; Huang, Z; Zhao, J	1
Nishio, M; Ochi, H; Shibamoto, Y; Tamaki, T	1
de Haas, M; de Klerk, J; Fijnheer, R; Hoekstra, O; Kramer, M; Quarles van Ufford, H; Tieks, B; Wittebol, S	1
Conti, PS; de Kerviler, E; Delbeke, D; Gisselbrecht, C; Meignan, M; Stroobants, S	1
Betrouni, N; Cazaentre, T; Huglo, D; Morschhauser, F; Prangère, T; Steinling, M; Vermandel, M	1
Berthou, C; Boisramé, S; Ianotto, JC; Querellou, S; Tempescul, A; Valette, G	1
Ambrosini, V; Castellucci, P; Fanti, S; Franchi, R; Maffione, AM; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, P	1
Lam, WW; Osmany, S	1
Boellaard, R; Hoekstra, OS; Zijlstra, JM	1
Abdel-Dayem, HM; Hafez, M; Omar, W; Riad, R; Sidhom, I; Zaky, I; Zamzam, M	1
Kennedy, GA; Morris, K; Ravi Kumar, A; Restall, J	1
Fujita, H; Inayama, Y; Ishigatsubo, Y; Sakata, S; Takeuchi, K; Tanaka, M; Tateishi, U; Tomita, N; Watanabe, R	1
Hicks, RJ; Hofman, MS	1
Kalkanis, DG; Paes, FM; Serafini, AN; Sideras, PA	1
Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J	2
Bilici, A; Canpolat, N; Gumus, M; Kefeli, U; Ozdemir, N; Salepci, T; Seker, M; Ustaalioglu, BB; Ustaalioglu, R; Yıldirim, E; Yilmaz, BE	1
Chassagne-Clément, C; Cimarelli, S; Heudel, PE; Janody, P; Lachenal, F; Ricard, F; Sebban, C	1
Ho, L; Negahban, A; Valenzuela, D; Wassef, H	1
Ahn, BC; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SW; Seo, JH; Shin, KM; Song, BI	1
Bramanti, S; Castagna, L; Ciceri, F; Corradini, P; Crippa, F; Crocchiolo, R; Dodero, A; Englaro, E; Fallanca, F; Frungillo, N; Miceli, R; Milani, R; Patriarca, F	1
Goldschmidt, N; Klein, M; Or, O; Paltiel, O; Savitsky, B	1
Hong, TS; Navarro, OM; Punnett, A; Shammas, A	1
Hanaoka, K; Hosono, M; Ishii, K; Komeya, Y; Shimono, T; Sumita, M; Tatsumi, Y; Tsuchiya, N; Usami, K; Yamazoe, Y	1
Huo, L; Li, F; Luo, Y; Zhang, T; Zhao, Y; Zhu, Z	1
Beaven, A; Broadwater, G; Chao, N; Coleman, RE; Goggins, T; Horwitz, M; Palmer, J; Rizzieri, D; Sullivan, K	1
Buriánková, E; Dušek, L; Flodr, P; Indrák, K; Jarkovský, J; Koranda, P; Kubová, Z; Kučerová, L; Mysliveček, M; Palová, M; Papajík, T; Procházka, V; Raida, L; Sedová, Z	1
Gönen, M; Gonzales, AM; Hunt, MA; Kirov, AS; Kowalski, A; McCann, P; Reiner, A; Schmidtlein, CR; Schöder, H; Terezakis, SA; Yahalom, J	1
Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL	1
Hutchings, M	1
Amati, A; Arena, V; Bellò, M; Bisi, G; Douroukas, A; Passera, R; Pelosi, E; Penna, D	1
Feustel, PJ; Karam, M; Nazeer, T; Vera, CD	1
D'Souza, M; Guliani, S; Jain, J; Kumari, R; Mondal, A; Pandey, SK; Sharma, R; Tripathi, M	1
Juweid, ME	2
Chabbert, V; Julian, A; Payoux, P; Wagner, T; Ysebaert, L	1
Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; van Leeuwen, MS; Vermoolen, MA	1
Hanaoka, K; Hosono, M; Ishii, K; Komeya, Y; Sumita, M; Tatsumi, Y; Tsuchiya, N; Usami, K; Yamazoe, Y	1
Alavi, A; Chamroonrat, W; Chen, W; Cheng, G; Torigian, DA; Zhuang, H	1
Buriankova, E; Dusek, L; Flodr, P; Hnatkova, M; Indrak, K; Jarkovsky, J; Koranda, P; Koza, V; Kubova, Z; Malan, A; Myslivecek, M; Papajik, T; Sedova, Z; Skopalova, M; Trneny, M	1
Blay, JY; Cimarelli, S; Ghesquières, H; Sebban, C; Sunyach, MP; Thiesse, P	1
Dammacco, F; Guariglia, R; Iodice, G; Musto, P; Reale, A; Ria, R; Vacca, A	1
Buriánková, E; Indrák, K; Kubová, Z; Kučerová, L; Melichar, B; Mikula, P; Mysliveček, M; Neoral, C; Papajík, T; Procházka, V; Raida, L; Sedová, Z; Starostka, D; Tichý, M	1
Chen, JH; Chen, YK; Kao, CH; Liang, JA; Tsui, CC; Yeh, CL	1
Liu, Y	1
Coya, J; del Campo, L; Gómez León, N; Hernández Maraver, D; Pinilla Fernández, I; Rodríguez-Vigil Junco, B	1
Asahi, S; Imamura, Y; Kimura, H; Kobayashi, M; Okazawa, H; Shimizu, K; Tsuchida, T; Tsuji, K; Tsujikawa, T	1
Bhattacharya, A; Das, R; Kashyap, R; Malhotra, P; Manohar, K; Mittal, BR; Varma, N; Varma, S	1
White, LR	1
Hatano, Y; Hayashi, Y; Hirose, Y; Hozumi, I; Inuzuka, T; Kasahara, S; Kato, J; Kimura, A; Koumura, A; Moriwaki, H; Nakamura, H; Sakurai, T; Takami, T; Tanaka, Y; Tsurumi, H; Yamada, M	1
Adib, S; Béron, A; Dewalle-Vignion, AS; Huglo, D; Lion, G; Petyt, G; Vermandel, M; Verscheure, L; Yeni, N	1
Guo, H; Iagaru, A; Mosci, C	1
Aversa, SM; Boscolo-Berto, R; Gardiman, M; Marino, D; Raduazzo, DI; Vezzaro, R	1
Bui, C; Fuller, S; Loh, H; Mansberg, R; Tow, J	1
Bakhshi, S; Dhawan, D; Kumar, R; Malhotra, A; Radhakrishnan, V; Sharma, P; Thulkar, S; Vishnubhatla, S	1
Il'in, NV; Khodzsibekova, MM; Kostenikov, NA; Mukhina, MS; Pozharisskiĭ, KM; Tiutin, LA	1
Chiewvit, S	1
Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD	1
Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Togashi, K; Watanabe, K	1
Bongaerts, AH; Glaudemans, AW; van Rheenen, RW	1
Chang, CC; Chang, CS; Chen, YW; Cho, SF; Lin, CY; Tu, HP	1
Bhattacharya, A; Malhotra, P; Manohar, K; Mittal, BR; Varma, S	1
Bhattacharya, A; Malhotra, P; Manohar, K; Mittal, BR; Raja, S; Varma, S	1
Del Ciello, A; Di Franco, D; Treglia, G	1
Elstrom, RL	1
Cheng, G; Servaes, S; Zhuang, H	1
Bal, C; Kumar, R; Malhotra, A; Sharma, A; Sharma, P; Singh, H; Suman, SK	1
Akkas, BE; Vural, GU	1
Kim, CG; Kim, DW; Kim, WH	1
Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Miura, M; Miyazaki, K; Nakahara, K; Ogo, E; Ohshima, K; Okamura, T; Suefuji, H; Suzuki, G; Takasu, K; Uozumi, J; Watanabe, Y	1
Fan, Y; Fu, L; Li, H; Tian, J; Wang, H; Xu, B	1
Gianolli, L; Mapelli, P; Picchio, M; Vanoli, EG	1
Finke, J; Fritsch, K; Hader, C; Haug, V; Illerhaus, G; Kasenda, B; Meyer, PT; Mix, M; Schorb, E; Weber, WA	1
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S	1
Ceccarelli, S; Lacanfora, A; Schillaci, O; Simonetti, G; Travascio, L	1
Buell, U; Cremerius, U; Fabry, U; Nowak, B; Osieka, R; Reinartz, P; Schaefer, W; Wildberger, JE; Zimny, M	1
Beguin, YP; Jerusalem, GH	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Zoe, H	1
Lowe, VJ; Wiseman, GA	1
Lin, EC	1
Grahek, D; Kerrou, K; Landman-Parker, J; Leverger, G; McNamara, D; Montravers, F; Talbot, JN; Wioland, M; Younsi, N	1
Balzarini, J; de Groot, T; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G	1
Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M	1
Bartsch, P; Belhocine, T; Green, A; Hustinx, R; Jerusalem, G; Rigo, P; Seidel, L; Steinmetz, N	1
Joyce, JM; Myers, DT; Petursson, SR; Pohland, ML	1
De Winter, F; Dierckx, RA; Kolindou, A; Lambert, B; Noens, L; Van De Wiele, C; Van Den Bossche, B	1
Alavi, A; Bagg, A; Baker, G; Downs, L; Elstrom, R; Guan, L; Kim, S; Mehrotra, A; Nakhoda, K; Pitsilos, S; Schuster, SJ; Vergilio, JA; Zhuang, H	1
Barrington, SF; Macdonald, EA; Mikhaeel, NG; O'Doherty, MJ; Schey, S	1
Daimaru, O; Imai, T; Itoh, S; Nagata, T; Ohishi, H; Shinai, T; Uchida, H; Yamane, T; Yoshiya, K	1
Beguin, Y; Fassotte, MF; Fillet, G; Foidart-Willems, J; Hustinx, R; Jérusalem, G; Silvestre, RM; Warland, V	1
Hoskin, PJ; O'Doherty, MJ	1
Mortelmans, L; Spaepen, K; Stroobants, S; Verhoef, G	1
Becherer, A; Jaeger, U; Kletter, K; Szabo, M	1
Bourguet, P	1
Eibl, M; Gallowitsch, HJ; Heinisch, M; Kresnik, E; Lind, P; Linkesch, W; Mikosch, P; Pipam, W; Unterweger, O; Zinke-Cerwenka, W	1
Blum, RH; Hicks, RJ; MacManus, M; Seymour, JF; Wirth, A	1
Beuthien-Baumann, B; Naumann, R	1
Balzarotti, M; Magagnoli, M; Santoro, A	1
Daimaru, O; Hashimoto, H; Ito, S; Kato, K; Nagata, T; Nishida, K; Uchida, H; Yamane, T; Yoshiya, K	1
Buchmann, I; Gfrörer, W; Glatting, G; Kotzerke, J; Leithäuser, F; Möller, P; Reske, SN; Schulte, M; Schultheiss, S; Vogg, AT	1
Byrne, DW; Delbeke, D; Greer, JP; Hallahan, DE; Lavely, WC; Morgan, DS; Price, RR	1
Joyce, JM; Kim, CE; Lichter, J; Patel, N	1
Alavi, A; Burns, J; Chiang, SB; Guan, L; Rebenstock, A; Zhuang, H	1
Lin, EC; Siegal, J	1
Constable, CJ; Fulham, MJ; Gradinscak, DJ; Mohamed, A	1
Döbert, N; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Podda, M; Wolter, M	1
Futatsubashi, M; Kanno, T; Kobayashi, M; Nakamura, F; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E	1
Comans, EF; Hoekstra, OS; Huijgens, PC; Jonkhoff, AR; Lammertsma, AA; Raijmakers, PG; Teule, GJ; v Tinteren, H; van der Hoeven, JJ; Zijlstra, JM	1
Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R; Jentzen, W; Müller, SP; Nowrousian, MR; Schütt, P	1
Carrasquillo, JA; Chen, CC; Little, RF; Nguyen, JD; Ryan, QC; Wilson, W	1
Chiusolo, P; Leone, G; Sica, S	1
Cui, RX; Zhou, Q	1
Borght, TV; Bosly, A; Krug, B; Mahy, N; Pirson, AS; Sonet, A	1
Bosi, A; Briganti, V; Castagnoli, A; Dini, C; Pagliai, F; Rigacci, L; Vaggelli, L	1
Cen, XN; Fan, Y; Fu, ZL; Wang, RF; Zhang, CL; Zhang, XM	1
Döbert, N; Grünwald, F; Hamscho, N; Kranert, WT; Menzel, C; Wördehoff, W	1
Goerres, GW; Hany, TF; Schaefer, NG; Seifert, B; Stumpe, KD; Taverna, C; von Schulthess, GK	1
Mackie, GC	1
Burton, C; Ell, P; Linch, D	1
Alavi, A; Kumar, R; Maillard, I; Schuster, SJ	1
Asaka, M; Nakada, K; Takei, T; Tamaki, N; Tsukamoto, E; Yamamoto, F; Zhao, S	1
Daimaru, O; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K	1
Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O	1
De Barsy, C; Depas, G; Dresse, MF; Fassotte, MF; Foidart, J; Hoyoux, C; Hustinx, R; Jerusalem, G; Paquet, N; Rigo, P	1
Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Marengo, M; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Zinzani, P	1
Franzius, C; Heindel, W; Hermann, S; Hunold, A; Jürgens, H; Pixberg, M; Schober, O; Wormanns, D	1
Avivi, I; Bomanji, JB; Ell, PJ; Goldstone, AH; Hart, DP; Linch, DC; Mackinnon, S; Morris, EC; Peggs, KS; Thomson, KJ	1
Alavi, A; El-Haddad, G; Kumar, R; Mavi, A; Xiu, Y; Zhuang, H	1
Alavi, A; Alinari, L; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Monetti, N; Nanni, C; Pourdehnad, M; Rubello, D; Stefoni, V; Tani, M; Zinzani, P	1
Blumstein, NM; Cheson, BD; Graham, MM; Juweid, ME; Link, BK; Menda, Y; Mottaghy, FM; Reske, SN; Ritchie, JM; Rohren, EM; Stolpen, A; Vose, JM; Wiseman, GA; Wooldridge, JE	1
Erdi, YE; Gönen, M; Green, D; Larson, SM; Noy, A; Schöder, H; Weng, L; Yeung, HW	1
Altehoefer, C; Finke, J; Herkel, C; Moser, E; Reinhardt, MJ	1
Fields, PA; Hutchings, M; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Leonard, JP	1
Apter, S; Ben-Bassat, I; Even-Sapir, E; Metser, U; Nagler, A; Naparstek, E; Perry, C; Polliack, A; Raanani, P; Shasha, Y	1
Avril, N; Jacobs, SA; Joyce, J; McCook, B; Torok, F; Vidnovic, N	1
Bibb, J; Hromas, R; Rabinowitz, I	1
Basu, S; Nair, N	1
Hany, TF; Strobel, K; Thuerl, CM	1
Faria, SC; Kazama, T; Macapinlac, HA; Mar, MV; Phongkitkarun, S; Podoloff, DA; Varavithya, V	1
Asakura, H; Mitani, M; Monden, T; Nishiyama, Y; Ohkawa, M; Takashima, H; Togami, T; Toyama, Y; Yamamoto, Y; Yokoe, K	1
Ak, I; Aydemir, B; Gülbaş, Z	1
Haioun, C; Itti, E; Meignan, M; Rahmouni, A; Reyes, F	1
Kanenishi, K; Komoto, D; Monden, T; Nishiyama, Y; Ohkawa, M; Ohno, M; Sasakawa, Y; Satoh, K; Toyama, Y; Yamamoto, Y	1
Alavi, A; Hernandez-Pampaloni, M; Takalkar, A; Yu, JQ; Zhuang, H	1
Guermazi, A; Juweid, ME	1
Arpaci, F; Arslan, N; Bulakbaşi, N; Kocaoğlu, M; Ozgüven, M; Oztürk, E	1
Altehoefer, C; Bucerius, J; Finke, J; Herkel, C; Joe, AY; Moser, E; Reinhardt, MJ	1
Ali, A; Cyriac, J; Karam, M; Nazeer, T; Novak, L; Nugent, F	1
Alavi, A; Andreadis, C; Berkowitz, A; Chong, EA; Downs, LH; Elstrom, R; Glatstein, E; Loren, AW; Luger, SM; Nasta, S; Porter, DL; Schuster, SJ; Siegel, DL; Stadtmauer, EA; Svoboda, J; Tsai, D	1
Delbeke, D; Frangoul, HA; Kuttesch, JF; Martin, W; Rhodes, MM; Shankar, S; Whitlock, JA	1
Mikhaeel, NG	1
Alavi, A; Newberg, A; Srinivas, SM; Sydow, BD	1
Al-Nahhas, A; Alavi, A; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D; Tehranipour, N; Zinzani, P	1
Gomes, M; Kotb, R; McFadden, N; Sawan, B; Schmutz, G; Turcotte, E	1
Bar Shalom, R; Ben Arush, MW; Haimi, M; Israel, O; Militianu, D; Postovsky, S; Zaidman, I	1
Bodet-Milin, C; Carlier, T; Chatal, JF; Couturier, O; Harousseau, JL; Oudoux, A; Querellou, S; Valette, F	1
Jhanwar, YS; Straus, DJ	1
de Bruin, HG; Rosso, SM; van den Bent, MJ; Wu, KL	1
Allen, C; Grimes, D; Sullivan, TJ; Valenzuela, AA; Wong, D	1
Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E; Zijlstra, JM	1
Coya, J; Gómez-León, N; Hernández-Maraver, D; Madero, R; Martín-Curto, L; Pinilla, I; Rodríguez-Vigil, B	1
Coya, J; Gomez-Leon, N; Hernandez-Maraver, D; Hernandez-Navarro, F; Madero, R; Martin-Curto, LM; Pinilla, I; Rodriguez-Vigil, B	1
Alinari, L; Ambrosini, V; Berkowitz, A; Castellucci, P; Elstrom, R; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Stefoni, V; Tani, M; Zinzani, PL	1
Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A	1
Canessa G, J; González E, P; Humeres A, P; Jofré M, MJ; Massardo V, T; Sierralta G, P	1
Rademaker, J	1
Cheson, BD; Coiffier, B; Connors, JM; Diehl, V; Dreyling, M; Federico, M; Fisher, RI; Gascoyne, RD; Hagenbeek, A; Hoppe, RT; Horning, SJ; Juweid, ME; Lister, TA; Pfistner, B; Rosen, ST; Specht, L; Stroobants, S; Tobinai, K; Vose, JM; Zucca, E	1
Armitage, J; Barker, A; Carucci, D; Cheson, B; Christian, M; Daube-Witherspoon, M; deGennaro, LJ; Dodd, L; Farrell, AT; Gastonis, C; Graham, M; Higley, HR; Horning, SJ; Juweid, M; Kelloff, GJ; Korn, E; Kostakoglu, L; Larson, SM; Lee, DB; Mills, GQ; O'connor, OA; Pazdur, R; Sargent, DJ; Schilsky, R; Shankar, LK; Siegel, BA; Sigal, E; Sigman, CC; Sullivan, DM; Timko, D; Wahl, RL; Wang, SJ; Weber, W; Wilson, W; Woodcock, J; Zelenetz, AD	1
Alavi, A; Bing, Z; Chamroonrat, W; Houseni, M; Yang, H; Zhuang, H	1
Bui, C; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL	1
Bonardel, G; Brisse, H; Edeline, V; Foehrenbach, H; Gaillard, JF; Maszelin, P; Michon, J; Neuenschwander, S; Pacquement, H	1
Bairey, O; Shpilberg, O	1
Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T	1
Halkar, RK; Kost, CB; Reilly, TB; Schuster, DM; Starsiak, MD	1
Endo, K; Handa, H; Hasegawa, M; Kojima, M; Matsushima, T; Murakami, H; Oriuchi, N; Saitoh, T; Tsukamoto, N; Yokohama, A	1
Specht, L	1
Blondet, C; Cimarelli, S; Constantinesco, A; Fohrer, C; Herbrecht, R; Imperiale, A	1
Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D	1
Fischer, K; Hany, TF; Jung, HH; Poryazova, R; Strobel, K	1
Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G	1
Even-Sapir, E; Herishanu, Y; Lerman, H; Lievshitz, G; Metser, U; Perry, C	1
Hicks, RJ; MacManus, MP; Seymour, JF	1
Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ	1
Weber, WA	1
Bar-Shalom, R; Eldad, DJ; Fischer, D; Ghersin, E; Halachmi, S; Keidar, Z	1
Mortelmans, L; Moulin-Romsee, G	1
Altamirano, J; Calvo, PS; Chalapud Revelo, JR; de la Garza Salazar, J; Esparza, JR; Estrada, G; Vera, SR	1
Hotta, T; Nagai, H; Nihashi, T; Terasawa, T	1
Hampson, FA; Shaw, AS	1
Li, G; Zhang, Y; Zhuang, H	1
Mortelmans, L; Moulin-Romsee, G; Spaepen, K; Stroobants, S	1
Bisi, G; Chiappella, A; Deandreis, D; Pelosi, E; Penna, D; Skanjeti, A; Vitolo, U	1
Bodet-Milin, C; Campion, L; Dupas, B; Gastinne, T; Goldenberg, DM; Harousseau, JL; Huglo, D; Kraeber-Bodéré, F; Le Gouill, S; Morschhauser, F; Wegener, WA	1
Bartenstein, P; Becker, C; Bröckel, N; Hacker, M; Hundt, W; la Fougère, C; Morhard, D; Pfluger, T; Schneider, V; Tiling, R	1
Chua, SC; Green, DJ; Rozalli, FI	1
Kasamon, YL; Wahl, RL	1
Bodet-Milin, C; Campion, L; Dupas, B; Kraeber-Bodéré, F; Le Gouill, S; Moreau, P	1
Johnston, PB; Micallef, IN; Wiseman, GA	1
Andemariam, B; Chadburn, A; Coleman, M; Elstrom, RL; Fahey, TJ; Furman, RR; Goldsmith, SJ; Leonard, JP; Martin, P; Niesvizky, R; Philips, SM; Rutherford, SC	1
Assanelli, A; Bernardi, M; Bordignon, C; Caligaris-Cappio, F; Canevari, C; Ciceri, F; Clerici, D; Crocchiolo, R; Fazio, F; Ferreri, A; Gianolli, L; Landoni, C; Lunghi, F; Peccatori, J; Servida, P; Stanghellini, ML; Tassara, M	1
Bisi, G; Chiappella, A; Deandreis, D; Gallo, E; Limerutti, G; Mancini, M; Pelosi, E; Penna, D; Pregno, P; Vitolo, U	1
Bishton, MJ; Hicks, RJ; Prince, MH; Seymour, JF; Westerman, DA; Wolf, M	1
Ahlström, H; Glimelius, B; Rehn, S; Rodriguez, M; Sundström, C	1
Bergman, J; Haaparanta, M; Joensuu, H; Klemi, PJ; Lapela, M; Leskinen, S; Lindholm, P; Minn, HR; Ruotsalainen, U; Söderström, KO; Solin, O	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G	1
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K	2
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH	1
Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A	1
Bares, R; Büll, U; Dempke, W; Galonska, P; Handt, S; Osieka, R	1
Golding, R; Hoekstra, OS; Huijgens, PC; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, GW	1
de Wit, M; Durig, J; Fiedler, W; Hossfeld, DK; Steffen, M	1
Beaney, RP; Chevretton, EB; Walsh, RM; Wong, WL	1
Dahlbom, M; Glaspy, J; Hawkin, RA; Hoh, CK; Kunkel, L; Lee, SJ; Maddahi, J; Phelps, ME; Rosen, P	1
Coleman, RE; Lee, VS; Martinez, S	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G	1
Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN	1
Beyer, W; Bumann, D; Clausen, M; de Wit, M; Herbst, K; Hossfeld, DK	1
Ahlström, H; Glimelius, B; Hagberg, H; Rehn, S; Rodriguez, M; Sundín, A; Sundström, C	1
Büll, U; Cremerius, U; Fabry, U; Günther, R; Hellwig, D; Neuerburg, J; Osieka, R; Thill, R; Wagenknecht, G	1
Bangerter, M; Diederichs, CG; Frickhofen, N; Guhlmann, A; Merkle, E; Moog, F; Reske, SN	1
Bangerter, M; Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Bangerter, M; Ellenrieder, V; Griesshammer, M; Hafner, M; Heimpel, H; Merkle, E; Moog, F; Reske, SN	1
Alavi, A; Alavi, JB; Bénard, F	1
Enne, W; Fuchs, C; Garbrecht, M; Hanauske, AR; Herz, M; Nerl, C; Römer, W; Schwaiger, M; Thödtmann, R; Weber, W; Ziegler, S	1
Beese, M; Beyer, W; Bücheler, E; Bumann, D; Clausen, M; de Wit, M; Lübeck, M	1
Rodriguez, M	1
Fuchs, C; Garbrecht, M; Römer, W; Schwaiger, M	1
Buck, A; Glanzmann, C; Steinert, HC; Stumpe, KD; Urbinelli, M; von Schulthess, GK	1
Bakheet, SM; Ezzat, A; Powe, J; Rostom, A	1
Buell, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P; Warland, V	1
Büll, U; Cremerius, U; Fabry, U; Kröll, U; Neuerburg, J; Osieka, R; Zimny, M	1
Beguin, Y; Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P	2
Collins, BT; Dunphy, FR; Lowe, VJ	1
Bergman, J; Haaparanta, M; Knuuti, J; Laine, H; Minn, H; Nuutinen, J; Ruotasalainen, U	1
Bohuslavizki, KH; Buchert, R; de Wit, M; Igel, B; Lorenzen, J	1
Hain, SF; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Buchmann, I; Moog, F; Reske, SN; Schirrmeister, H	1
Kaminski, MS; Kison, PV; Rommelfanger, SG; Torizuka, T; Wahl, RL; Zasadny, KR	1
Gibson, P; Hoskin, P; Lowe, J; McMillan, A; Shah, N; wong, WL	1
Kim, HC; Kim, HS; Lee, J; Park, CH	1
Hwang, K; Kim, H; Kim, HC; Kim, S; Pai, M; Park, CH; Yoon, S	1
Fridrik, M; Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G	1
Avril, N; Schwaiger, M; Stahl, A; Weber, WA	1
Balzarini, J; Bormans, G; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Van Steenweghen, S; Vandenberghe, P; Vanuytsel, L; Verhoef, G	1
Kuwert, T	1
Bakheet, R; Bakheet, SM; Durakovic, A; Ezzat, A; Hussain, S; Tulbah, A	1
Hwang, KH; Kim, MK; Kim, S; Park, CH; Yoon, SN	1
Kanakura, Y; Kitayama, H; Nakamura, H; Nishimura, T; Sugahara, H; Tatsumi, M; Tokita, N	1
Segall, GM	1
Hain, S; Maisey, MN; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H	1
Bares, R; Büll, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Bar-Shalom, R; Goldsmith, SJ; Mor, M; Yefremov, N	1
Ariannejad, M; Czernin, J; Meta, J; Phelps, ME; Rao, J; Sayre, J; Schöder, H; Valk, PE; Yap, C	1
Beguin, Y; Fassotte, MF; Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P	1
Domagk, D; Domschke, W; Franzius, CH; Sciuk, J; Seidel, M; Ullerich, H	1
Hosono, T; Kawamura, T; Kurabayashi, M; Maeno, T; Maeno, Y; Nagai, R; Sando, Y; Sato, M; Suga, T; Tajima, S	1
Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P	1
Alavi, A; Matthies, A; Schuster, SJ	1
Buchmann, I; Reske, SN	1
Alavi, A; Ghesani, N; Hongming, Z; Mozley, D; Schusper, S; Shih, WJ	1
Mortelmans, L; Spaepen, K	1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M	1
Beuthien-Baumann, B; Bredow, J; Ehninger, G; Franke, WG; Kittner, T; Kropp, J; Naumann, R; Vaic, A	1
Fisher, R; Hicks, RJ; Januszewicz, H; MacManus, MP; Prince, M; Ryan, G; Seymour, JF; Ware, R; Wirth, A; Wolf, M	1
Kaplan, LD	1
Hoskin, PJ	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Vallabhajosula, S	1
Higuchi, T	1
Haberkorn, U; Reisser, C; Strauss, LG	1
Bischoff, H; Knopp, MV; Oberdorfer, F; van Kaick, G	1
Daemen, BJ; Elsinga, PH; Konings, AW; Lemstra, W; Paans, AM; Vaalburg, W	1
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K	1
Joensuu, H; Leskinen-Kallio, S; Någren, K; Ruotsalainen, U; Teräs, M	1
Paul, R	1

Reviews

51 review(s) available for fluorodeoxyglucose f18 and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Current Role of Functional Imaging in the Management of Lymphoma. Current oncology reports, 2021, 11-04, Volume: 23, Issue:12 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Practice Guidelines as Topic	2021
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma. Medicina clinica, 2020, 01-24, Volume: 154, Issue:2 Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult	2020
Update on Hodgkin lymphoma from a radiologist's perspective. Clinical imaging, 2020, Volume: 65 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Tomography, X-Ray Computed	2020
Diagnostic Yield of Extensive Systemic Staging Including Whole-body 18F-fluoro-deoxy-glucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:11 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:8 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neuroimaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2021
Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update. Cancer, 2021, 10-15, Volume: 127, Issue:20 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tumor Burden	2021
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Jul-01, Volume: 28, Issue:7 Topics: Antineoplastic Agents; Consensus; Contrast Media; Disease Progression; Disease-Free Survival; Endpoint Determination; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Response Evaluation Criteria in Solid Tumors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2017
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Treatment Outcome	2017
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Precision Medicine	2017
The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. European journal of pediatrics, 2013, Volume: 172, Issue:6 Topics: Chemoradiotherapy; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2013
The predictive value of interim and final [18F] fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin's lymphoma: a meta-analysis. BioMed research international, 2013, Volume: 2013 Topics: Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Proportional Hazards Models; Publication Bias; Rituximab	2013
Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma. The British journal of radiology, 2014, Volume: 87, Issue:1042 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed	2014
Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies. Cancer treatment and research, 2015, Volume: 165 Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome	2015
Non-Hodgkin's Lymphoma of Multiple Skeletal Muscles Involvement Seen on FDG PET/CT Scans. Medicine, 2015, Volume: 94, Issue:18 Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis. Nuclear medicine communications, 2016, Volume: 37, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Stem Cell Transplantation	2016
The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma. Nuclear medicine communications, 2017, Volume: 38, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms	2017
Measuring response with FDG-PET: methodological aspects. The oncologist, 2009, Volume: 14, Issue:4 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms	2009
PET imaging in lymphoma. Expert review of hematology, 2009, Volume: 2, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2009
FDG-PET/CT in lymphoma. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed	2011
Magnetic resonance imaging of malignant lymphoma. Expert review of hematology, 2011, Volume: 4, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2011
F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis. Clinical nuclear medicine, 2011, Volume: 36, Issue:7 Topics: Bone Marrow; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Quality Assurance, Health Care; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT. Annals of nuclear medicine, 2011, Volume: 25, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Positron-Emission Tomography; Sarcoma, Kaposi; Tomography, X-Ray Computed; Tuberculosis	2011
Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Carbon Radioisotopes; Cell Division; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Methionine; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed	2002
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma]. Revue medicale de Liege, 2002, Volume: 57, Issue:12 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2002
Positron emission tomography in the management of lymphomas: a summary. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Predictive Value of Tests; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Prognostic value of FDG-PET in malignant lymphoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003, Volume: 47, Issue:1 Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Indium Radioisotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed; Treatment Outcome	2003
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2003
Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed	2003
The role of PET imaging in lymphoma. British journal of haematology, 2004, Volume: 126, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Treatment Outcome	2004
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2004, Volume: 42, Issue:6 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting	2004
FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clinical nuclear medicine, 2005, Volume: 30, Issue:4 Topics: Adrenal Gland Neoplasms; Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases	2005
The role of FDG-PET imaging in the management of lymphoma. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:2 Topics: Bone Marrow; Clinical Trials as Topic; Disease Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome	2004
How much intravenous contrast is needed in FDG-PET/CT? Nuklearmedizin. Nuclear medicine, 2005, Volume: 44 Suppl 1 Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma. Clinical lymphoma & myeloma, 2006, Volume: 6, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2006
Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33 Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Treatment Outcome	2006
The role of PET in lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:8 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2006
[Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas]. Revista medica de Chile, 2006, Volume: 134, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity	2006
Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma? Acta haematologica, 2007, Volume: 118, Issue:1 Topics: Biopsy, Needle; Bone Marrow; Bone Marrow Examination; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Non-Hodgkin; Male; Patient Selection; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Unnecessary Procedures	2007
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Seminars in radiation oncology, 2007, Volume: 17, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome	2007
Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiologic clinics of North America, 2007, Volume: 45, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2007
Overview of early response assessment in lymphoma with FDG-PET. Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Volume: 7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals	2007
18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2008
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2008
Response assessment in lymphoma. Clinical radiology, 2008, Volume: 63, Issue:2 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Current opinion in oncology, 2008, Volume: 20, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Treatment Outcome	2008
Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma. Bone marrow transplantation, 2008, Volume: 41, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous	2008
The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Seminars in nuclear medicine, 2001, Volume: 31, Issue:3 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Novel imaging techniques in NHL: clinical results with PET imaging. Annals of hematology, 2001, Volume: 80 Suppl 3 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:3 Topics: Fluorine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2001
[Positron emission tomography of the thorax. The current clinical status]. Der Radiologe, 1992, Volume: 32, Issue:6 Topics: Carcinoma, Bronchogenic; Deoxyglucose; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Tomography, Emission-Computed	1992

Trials

34 trial(s) available for fluorodeoxyglucose f18 and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia, 2022, Volume: 36, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine	2022
Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells. Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:13 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nomograms; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes	2023
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6 Topics: Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography	2021
Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm. Nuclear medicine communications, 2018, Volume: 39, Issue:1 Topics: Adult; Automation; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Robotic Surgical Procedures; Young Adult	2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 07-10, Volume: 36, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine	2018
Phase II study of first-line (131)I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic (18)F-fluorodeoxyglucose positron emission tomography. Leukemia & lymphoma, 2015, Volume: 56, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2015
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Allografts; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Survival Rate	2015
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Annals of hematology, 2009, Volume: 88, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Metabolism; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Remission Induction; Survival Analysis; T-Lymphocytes; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platinum Compounds; Positron-Emission Tomography; Prognosis; Risk Assessment; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult	2009
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult	2010
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity	2011
90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6 Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2011
[Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT]. Medicina clinica, 2011, Oct-08, Volume: 137, Issue:9 Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Bone Marrow Examination; Contrast Media; Cross-Sectional Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nuclear Medicine; Observer Variation; Physical Examination; Positron-Emission Tomography; Prospective Studies; Radiology; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Tomography, X-Ray Computed; Young Adult	2011
Roles and limitations of FDG PET in pediatric non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Reference Standards; Remission Induction; Whole Body Imaging; Young Adult	2012
Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Bone marrow transplantation, 2002, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation, Autologous	2002
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Annals of nuclear medicine, 2002, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting	2002
Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:9 Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Life Tables; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Nuclear medicine communications, 2002, Volume: 23, Issue:11 Topics: Adolescent; Adult; Citrates; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Drug Monitoring; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2004
FDG-PET/CT in re-staging of patients with lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome	2004
18F-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin's lymphoma. Annals of nuclear medicine, 2004, Volume: 18, Issue:6 Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2004
Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome	2004
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction. Journal of nuclear medicine technology, 2004, Volume: 32, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2 Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antigens, CD20; Blood Platelets; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Pleural Effusion; Positron-Emission Tomography; Radioimmunotherapy; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2005
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood, 2007, Jan-15, Volume: 109, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Transplantation, Autologous; Treatment Outcome	2007
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography. Haematologica, 2008, Volume: 93, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Sialic Acid Binding Ig-like Lectin 2; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2008
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica, 2008, Volume: 93, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiology, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy. Haematologica, 2008, Volume: 93, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioimmunotherapy; Remission Induction; Rituximab; Time Factors; Treatment Outcome	2008
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1 Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Whole-Body Counting	1997
[18F] FDG PET in gastric non-Hodgkin's lymphoma. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. European journal of nuclear medicine, 1998, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1998
Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:8 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting	2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:6 Topics: Adult; Aged; Bone Marrow; Colon; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed	2001
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer, 2002, Feb-15, Volume: 94, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002

Other Studies

376 other study(ies) available for fluorodeoxyglucose f18 and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis. The Journal of international medical research, 2021, Volume: 49, Issue:8 Topics: Aged; Biopsy; Brain; Central Nervous System; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed	2021
Armor sign on PET-CT in a young male with non-Hodgkin's lymphoma. International journal of hematology, 2022, Volume: 115, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Tuberculosis, Pleural; Young Adult	2022
Discordant Metabolic Response on 18F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms	2022
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma. Hematological oncology, 2022, Volume: 40, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes	2022
[Correlation and Influencing Factors of SUVmax and Ki-67 in Non-Hodgkin Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2022
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT. Journal of hematology & oncology, 2022, 03-26, Volume: 15, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies	2022
Prognostic value of pre-transplantation total metabolic tumor volume on International journal of hematology, 2022, Volume: 116, Issue:4 Topics: Fluorodeoxyglucose F18; Glucose; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden	2022
Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT. JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:6 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization. Scientific reports, 2022, 07-25, Volume: 12, Issue:1 Topics: Brain; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Hyperlactatemia; Lactates; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2022
64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rituximab	2023
Vertebral photopenia on [67Ga]Ga-citrate and [18F]FDG PET/CT imaging in a patient with non-Hodgkin lymphoma. Nuclear medicine review. Central & Eastern Europe, 2023, Volume: 26, Issue:0 Topics: Citrates; Citric Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2023
Treatment Resulting Changes in Volumes of High- International journal of molecular sciences, 2023, Jan-21, Volume: 24, Issue:3 Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Orbit; Pericardium; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine	2023
Occult optic nerve neurolymphomatosis of T-lymphoblastic lymphoma detected by PET/MRI. British journal of haematology, 2023, Volume: 201, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neurolymphomatosis; Optic Nerve; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma. Haematologica, 2023, 11-01, Volume: 108, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Retrospective Studies	2023
Primary Urethra Non-Hodgkin Lymphoma in a 46-Year-Old Man on FDG PET/CT. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urethra	2023
A hybrid few-shot multiple-instance learning model predicting the aggressiveness of lymphoma in PET/CT images. Computer methods and programs in biomedicine, 2024, Volume: 243 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2024
TAC y PET/TC con 18-FDG para evaluar la respuesta al tratamiento en linfoma de Hodgkin y no Hodgkin. Gaceta medica de Mexico, 2019, Volume: 155, Issue:4 Topics: Adolescent; Adult; Aged; Child; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2019
Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study. Nuclear medicine communications, 2020, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve	2020
Modified hydrodissection for percutaneuous biopsy of small lesions: the "marshmallow" technique. Diagnostic and interventional radiology (Ankara, Turkey), 2020, Volume: 26, Issue:1 Topics: Aged; Dissection; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiology, Interventional; Safety	2020
Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement. Nuclear medicine communications, 2020, Volume: 41, Issue:6 Topics: Bone Marrow; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Risk; Tumor Burden	2020
Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT. Minerva medica, 2021, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Heart Transplantation; Hodgkin Disease; Humans; Hyperplasia; Immunocompromised Host; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals	2021
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma. The Korean journal of internal medicine, 2021, Volume: 36, Issue:Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
ΔSUVmax for interim PET in DLBCL: old is new. Blood, 2020, 06-18, Volume: 135, Issue:25 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis	2020
Non-Hodgkin Lymphoma With an Atypical Presentation: A Solitary Paravertebral Mass on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Spine	2020
18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach. Nuclear medicine communications, 2020, Volume: 41, Issue:12 Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Watchful Waiting	2020
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia Biomedica : revista del Instituto Nacional de Salud, 2020, 10-30, Volume: 40, Issue:Supl. 2 Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms	2020
Differentiating gastric cancer and gastric lymphoma using texture analysis (TA) of positron emission tomography (PET). Chinese medical journal, 2020, Nov-18, Volume: 134, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms	2020
High-resolution 18F-FDG PET/MR offers better treatment evaluation than PET/CT or MRI in CNS lymphoma. Japanese journal of clinical oncology, 2021, Apr-30, Volume: 51, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma. Leukemia & lymphoma, 2021, Volume: 62, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiopharmaceuticals	2021
Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin's Abscess on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, 03-01, Volume: 46, Issue:3 Topics: Abscess; Bartholin's Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Vulva	2021
A Case of Solitary Laryngotracheal Lymphoma Evaluated by 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Aug-01, Volume: 46, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tracheal Neoplasms	2021
[Prognostic value of interim PET/CT in non-hodgkin lymphoma]. Revista medica de Chile, 2020, Volume: 148, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed	2020
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation. Scientific reports, 2021, 04-29, Volume: 11, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult	2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:11 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies	2021
Prognostic value of [ European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:12 Topics: Adenine; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Piperidines; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tumor Burden	2021
The value of bone marrow biopsy for staging of patients with primary CNS lymphoma. Neuro-oncology, 2021, 12-01, Volume: 23, Issue:12 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Retrospective Studies	2021
Are treatment response assessment maps (TRAMs) and British journal of haematology, 2021, Volume: 195, Issue:1 Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx. Acta medica Okayama, 2021, Volume: 75, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies	2021
Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT. Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:2 Topics: Choline; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Sternum	2017
Role of narrow band imaging in the diagnostics of sinonasal pathology. BMJ case reports, 2017, Apr-28, Volume: 2017 Topics: Aged; Diagnosis, Differential; Endoscopy; Fluorodeoxyglucose F18; Humans; Light; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mediastinum; Mucous Membrane; Narrow Band Imaging; Nasal Cavity; Neck; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography	2017
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2017
Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leukemia & lymphoma, 2017, Volume: 58, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tertiary Care Centers	2017
FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:9 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
Adaptive region-growing with maximum curvature strategy for tumor segmentation in Physics in medicine and biology, 2017, Jul-07, Volume: 62, Issue:13 Topics: Algorithms; Calibration; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Phantoms, Imaging; Positron-Emission Tomography	2017
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics. The Israel Medical Association journal : IMAJ, 2017, Volume: 19, Issue:6 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Rituximab; Sex Factors; Tomography, X-Ray Computed; Vincristine	2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET". European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:13 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
A Huge Thoracic Aortic Aneurysm. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018, Volume: 55, Issue:2 Topics: Aged; Antineoplastic Agents; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Image-Guided Biopsy; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2018
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 47, Issue:5 Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hodgkin Disease; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging	2018
Burkitt non-Hodgkin lymphoma presenting with mental neuropathy ('numb chin' syndrome) in an HIV-positive patient. International journal of STD & AIDS, 2018, Volume: 29, Issue:6 Topics: Adult; Burkitt Lymphoma; Chin; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography	2018
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma. European journal of radiology, 2018, Volume: 99 Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; ROC Curve; Tumor Burden; Ultrasonography	2018
PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients. European radiology, 2018, Volume: 28, Issue:7 Topics: Adolescent; Adult; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Cell Differentiation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult	2018
A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology. The American journal of case reports, 2018, Mar-14, Volume: 19 Topics: Aged; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging	2018
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 48, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; ROC Curve; Whole Body Imaging	2018
Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone. BMJ case reports, 2018, Apr-17, Volume: 2018 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Humeral Head; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron Emission Tomography Computed Tomography; Remission Induction; Treatment Outcome	2018
18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Medicine, 2018, Volume: 97, Issue:16 Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Israel; Lymphoid Tissue; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Tissue Distribution	2018
Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment. Medicine, 2018, Volume: 97, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Adnexal and Skin Appendage; Orbit; Orbital Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome	2018
Annals of nuclear medicine, 2018, Volume: 32, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden; Young Adult	2018
Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas. Clinical physiology and functional imaging, 2019, Volume: 39, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Automation; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Liver; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Young Adult	2019
False positive finding of F18-FDG in non-Hodgkins lymphoma; an inflamed appendix. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6 Topics: Adult; Appendectomy; Appendicitis; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Adolescent; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals	2018
The clinical value of imaging in primary cutaneous lymphomas: Role of high resolution ultrasound and PET-CT. The British journal of radiology, 2019, Volume: 92, Issue:1095 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin; Skin Neoplasms; Ultrasonography; Young Adult	2019
Fluorodeoxyglucose Detected Changes in Brain Metabolism After Chemotherapy in Pediatric Non-Hodgkin Lymphoma. Pediatric neurology, 2019, Volume: 92 Topics: Adolescent; Antineoplastic Agents; Brain; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies	2019
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:6 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2019
High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve. BMJ case reports, 2019, Mar-06, Volume: 12, Issue:3 Topics: Aged; Arm; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Median Nerve; Neurolymphomatosis; Positron-Emission Tomography; Radiotherapy; Ultrasonography; Ultrasonography, Doppler, Duplex	2019
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report. Medicine, 2019, Volume: 98, Issue:11 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine	2019
Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:6 Topics: Antineoplastic Agents; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Histiocytes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen	2019
Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:6 Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Receptors, Chimeric Antigen; T-Lymphocytes	2019
Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma. ESC heart failure, 2019, Volume: 6, Issue:4 Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muscle, Skeletal; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2019
Prognostic significance of pretreatment ¹⁸F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab. Acta haematologica, 2013, Volume: 130, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Recurrence; Rituximab; Tomography, X-Ray Computed	2013
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:9 Topics: Adult; Aged; False Positive Reactions; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma. Future oncology (London, England), 2013, Volume: 9, Issue:6 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Radiography; Treatment Outcome	2013
Primary ovarian non-Hodgkin's lymphoma. BMJ case reports, 2013, Jul-29, Volume: 2013 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2013
Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET. Anticancer research, 2013, Volume: 33, Issue:8 Topics: beta 2-Microglobulin; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Reference Standards	2013
Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter reading. Nuklearmedizin. Nuclear medicine, 2013, Volume: 52, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Germany; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult	2013
[Prognostic significance of 18F-FDG PET/CT in aggressive non- Hodgkin's lymphoma: a 10-year retrospective study on 105 cases]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis	2013
Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT. Hematological oncology, 2014, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult	2014
Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdominal imaging, 2014, Volume: 39, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2014
Focal and diffuse FDG uptake patterns of endotracheal lymphoma. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Trachea	2014
Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; ROC Curve; Thymine; Treatment Outcome	2014
Successful surgical treatment for pulmonary crystal-storing histiocytosis following the onset of gastric non-hodgkin lymphoma. Journal of clinical and experimental hematopathology : JCEH, 2013, Volume: 53, Issue:3 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Gene Rearrangement; Histiocytes; Histiocytosis; Humans; Immunoglobulin Heavy Chains; Immunoglobulins; Immunohistochemistry; Lung; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Solitary Pulmonary Nodule; Stomach Neoplasms; Treatment Outcome	2013
[Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2014
A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. International journal of radiation oncology, biology, physics, 2014, Jun-01, Volume: 89, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; Nuclear Physics; Positron-Emission Tomography; Prospective Studies; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2014
Evaluation of primary bone lymphoma and the importance of positron emission tomography. Acta orthopaedica et traumatologica turcica, 2014, Volume: 48, Issue:3 Topics: Adolescent; Biopsy; Bone Neoplasms; Chemoradiotherapy; Child; Femoral Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Sensitivity and Specificity	2014
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-20, Volume: 32, Issue:27 Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2014
[Synchronous hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma in chronic hepatitis C patient]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Sep-25, Volume: 64, Issue:3 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gadolinium DTPA; Genotype; Hepatitis B virus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Epiphyseal presentation of non-Hodgkin's lymphoma of bone in two pediatric patients--one with primary lymphoma of bone. Skeletal radiology, 2015, Volume: 44, Issue:4 Topics: Adolescent; Biopsy; Child; Diagnosis, Differential; Epiphyses; Femur; Fluorodeoxyglucose F18; Humans; Knee; Lymphoma; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2015
[A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2014, Volume: 37, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Prognosis; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Young Adult	2014
Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT. Bone marrow transplantation, 2015, Volume: 50, Issue:1 Topics: Adolescent; Adult; Aged; Allografts; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Stem Cell Transplantation; Survival Rate	2015
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. British journal of haematology, 2015, Volume: 168, Issue:6 Topics: Adolescent; Biopsy; Child; Child, Preschool; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2015
Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"? Leukemia & lymphoma, 2015, Volume: 56, Issue:5 Topics: Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography	2015
Complementary roles of bone scintigraphy and MR imaging in the detection and long-term follow-up of primary non-Hodgkin's bone lymphoma in a child-case report. Skeletal radiology, 2015, Volume: 44, Issue:6 Topics: Adolescent; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2015
Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer. Endocrine, 2015, Volume: 50, Issue:1 Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms	2015
[Metabolic activity measured by ¹⁸F-FDG PET/CT in newly diagnosed patients with non-Hodgkin lymphoma: correlation with immunophenotype]. Zhonghua yi xue za zhi, 2014, Sep-09, Volume: 94, Issue:33 Topics: Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2014
Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET. American journal of hematology, 2015, Volume: 90, Issue:3 Topics: Aged; Bone Marrow; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Osteitis Deformans; Positron-Emission Tomography; Radiography	2015
Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance. European journal of haematology, 2015, Volume: 95, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2015
Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2015, Volume: 36, Issue:4 Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden	2015
High liver FDG uptake on PET/CT in patient with lymphoma diagnosed with hereditary hemochromatosis. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Fluorodeoxyglucose F18; Hemochromatosis; Humans; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jun-01, Volume: 21, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Whole Body Imaging	2015
Diagnosis, PET/CT imaging, and treatment of extranodal non-Hodgkin lymphoma in keratinized gingiva: a case report. Journal of oral science, 2015, Volume: 57, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Immunohistochemistry; Keratins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Oral Surgical Procedures; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiopharmaceuticals	2015
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. American journal of hematology, 2015, Volume: 90, Issue:8 Topics: Adolescent; Adult; Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma. Radiology, 2015, Volume: 277, Issue:2 Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Treatment Outcome	2015
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings. World neurosurgery, 2015, Volume: 84, Issue:4 Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome	2015
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Clinical radiology, 2015, Volume: 70, Issue:11 Topics: Adolescent; Adult; Aged; Analysis of Variance; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:13 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Asymptomatic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2016
The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease. Orbit (Amsterdam, Netherlands), 2015, Volume: 34, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbital Diseases; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
[PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma. La Radiologia medica, 2016, Volume: 121, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult	2016
Primary tracheal and bronchial lymphoma displayed on 18F-FDG PET/CT imaging. Clinical nuclear medicine, 2015, Volume: 40, Issue:12 Topics: Bronchial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms	2015
Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient Management. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
False-Positive 18F-FDG PET/CT Imaging: Dramatic "Flare Response" After Rituximab Administration. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed	2016
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Investigative radiology, 2016, Volume: 51, Issue:3 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2016
Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Scrotum; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder	2016
The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2016, Volume: 37, Issue:7 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2016
Coincidental Observation of Global Hypometabolism in the Brain on PET/CT of an AIDS Patient With High-Grade Pulmonary Non-Hodgkin Lymphoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: AIDS Dementia Complex; Brain; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdominal radiology (New York), 2016, Volume: 41, Issue:7 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2016
18F-FDG PET Detection of a Medullary Thyroid Carcinoma in a Patient With SMZL. Clinical nuclear medicine, 2016, Volume: 41, Issue:10 Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Splenic Neoplasms; Thyroid Neoplasms	2016
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas. European radiology, 2017, Volume: 27, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Young Adult	2017
Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Nuclear medicine communications, 2016, Volume: 37, Issue:12 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms	2016
Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma. The Journal of laryngology and otology, 2016, Volume: 130 Suppl 4 Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult	2017
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. World journal of gastroenterology, 2016, Sep-14, Volume: 22, Issue:34 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Young Adult	2016
High-risk interim PET negative patients in Hodgkin's lymphoma. The Lancet. Haematology, 2016, Volume: 3, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed	2016
Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Young Adult	2016
Pediatric Brown Adipose Tissue on Journal of nuclear medicine technology, 2017, Volume: 45, Issue:2 Topics: Adipose Tissue, Brown; Adolescent; Artifacts; Biological Transport; Diazepam; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies	2017
[ Cancer, 2017, Aug-01, Volume: 123, Issue:15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Ontario; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Registries; Young Adult	2017
A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma. Haematologica, 2008, Volume: 93, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Lymphoma, Non-Hodgkin; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab	2008
New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiologic clinics of North America, 2008, Volume: 46, Issue:2 Topics: Clinical Trials as Topic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2008
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. Nuclear medicine communications, 2008, Volume: 29, Issue:8 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Ultrasonography	2008
Primary multifocal osseous lymphoma in a child. Pediatric radiology, 2008, Volume: 38, Issue:12 Topics: Arthralgia; Biopsy; Bone Neoplasms; Child; Diagnosis, Differential; Female; Femur; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed; Whole Body Imaging	2008
PET/CT appearance of non-Hodgkin lymphoma of the vermiform appendix. Clinical nuclear medicine, 2008, Volume: 33, Issue:10 Topics: Appendix; Cecal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. American journal of clinical oncology, 2008, Volume: 31, Issue:5 Topics: Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2008
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult	2009
[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas. Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors	2008
Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3 Topics: Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma. Annals of nuclear medicine, 2008, Volume: 22, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vincristine	2008
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:6 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma. Clinical nuclear medicine, 2009, Volume: 34, Issue:4 Topics: Aged; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer. Clinical nuclear medicine, 2009, Volume: 34, Issue:3 Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed	2009
Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values. International journal of clinical oncology, 2009, Volume: 14, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-2	2009
Tumor metabolic phenotypes on 18F FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals	2009
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy. Leukemia & lymphoma, 2009, Volume: 50, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies; Rituximab; Tomography, X-Ray Computed	2009
Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier. Leukemia & lymphoma, 2009, Volume: 50, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed	2009
Quantification of local tumor response to fractionated radiation therapy for non-Hodgkin lymphoma using weekly 18F-FDG PET/CT imaging. International journal of radiation oncology, biology, physics, 2010, Mar-01, Volume: 76, Issue:3 Topics: Dose Fractionation, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction; Time Factors; Tomography, X-Ray Computed; Tumor Burden	2010
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. Nuclear medicine communications, 2009, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography	2009
[18F-FDG uptake of lymphoma lesions of various histological subtypes]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2009
Non-Hodgkin's lymphoma of supraclavicular lymph nodes can mimic metastasis of breast cancer during chemotherapy on FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Adult; Breast Neoplasms; Clavicle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Intraspinal canal neurolymphomatosis detected by FDG-PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Spinal Canal; Tomography, X-Ray Computed	2009
On the added value of baseline FDG-PET in malignant lymphoma. Molecular imaging and biology, 2010, Volume: 12, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Whole Body Imaging; Young Adult	2010
Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. The oncologist, 2009, Volume: 14 Suppl 2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2009
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Fuzzy Logic; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Retrospective Studies; Treatment Outcome; Tumor Burden	2010
18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract. Annals of hematology, 2010, Volume: 89, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organoplatinum Compounds; Paranasal Sinus Neoplasms; Paranasal Sinuses; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Tomography, Emission-Computed; Vincristine	2010
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2009, Volume: 34, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy	2009
Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:11 Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Netherlands; Positron-Emission Tomography; Prognosis; Reference Standards; Treatment Outcome	2009
False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma. Nuclear medicine communications, 2010, Volume: 31, Issue:3 Topics: Burkitt Lymphoma; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed	2010
Post-therapy calcification can result in false-positive fluorodeoxyglucose positron emission tomography scans in patients with non-Hodgkin's lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcinosis; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Young Adult	2010
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Biopsy; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity	2010
Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Biopsy; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2010
FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics : a review publication of the Radiological Society of North America, Inc, 2010, Volume: 30, Issue:1 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Young Adult	2010
The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2010
Primary spinal epidural non-Hodgkin lymphoma demonstrated by FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:7 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Spinal Cord Neoplasms; Tomography, X-Ray Computed	2010
Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2010, Volume: 35, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Pneumonia; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed	2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transp Cancer, 2010, Nov-01, Volume: 116, Issue:21 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Graft vs Host Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2010
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Annals of hematology, 2011, Volume: 90, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Young Adult	2011
Osteonecrosis in an adolescent with non-Hodgkin lymphoma resembling a new metastatic lesion on (18)F-FDG PET/CT. Pediatric radiology, 2010, Volume: 40 Suppl 1 Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2010
Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions. Annals of nuclear medicine, 2010, Volume: 24, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Brain; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2010
Unexpected primary osseous lymphoma as the cause of lactic acidosis in a patient suffering from pancreatitis. Clinical nuclear medicine, 2010, Volume: 35, Issue:10 Topics: Acidosis, Lactic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatitis; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone marrow transplantation, 2011, Volume: 46, Issue:6 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult	2011
[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies. International journal of radiation oncology, biology, physics, 2011, Nov-01, Volume: 81, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; New York City; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2011
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. Cancer, 2011, Mar-01, Volume: 117, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult	2011
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Features of large cell transformation of indolent lymphomas as observed on sequential PET/CT. Nuclear medicine communications, 2011, Volume: 32, Issue:3 Topics: Biological Transport; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2011
Sagittal sinus tumor thrombosis in a case of NHL demonstrated on F-18 FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Sagittal Sinus Thrombosis; Tomography, X-Ray Computed	2011
FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2011
Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2011, Volume: 32, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone Marrow; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Spine; Time Factors; Young Adult	2011
Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:8 Topics: Adolescent; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT. Neoplasma, 2011, Volume: 58, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma. Clinical nuclear medicine, 2011, Volume: 36, Issue:7 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clinical nuclear medicine, 2011, Volume: 36, Issue:8 Topics: Adolescent; Adult; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Diseases	2011
Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging? Leukemia & lymphoma, 2011, Volume: 52, Issue:11 Topics: Algorithms; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009). Molecular imaging and biology, 2012, Volume: 14, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Diffuse skeletal muscles uptake of [18F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18 Topics: Adult; Biological Transport; Biopsy; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Positron-Emission Tomography	2011
Evaluation of PET volume segmentation methods: comparisons with expert manual delineations. Nuclear medicine communications, 2012, Volume: 33, Issue:1 Topics: Algorithms; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2012
Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on 18F-FDG PET/CT. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Peripheral Nerves; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Aggressive non-Hodgkin's lymphoma mimicking unilateral transitional cell carcinoma of renal pelvis. The risk of making a diagnostic mistake. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2011, Volume: 83, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Neoplasms; Kidney Pelvis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Risk; Tomography, X-Ray Computed; Treatment Outcome	2011
Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:2 Topics: Abdomen; Edema; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography, Abdominal; Tomography, X-Ray Computed	2012
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study. Radiology, 2012, Volume: 262, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Contrast Media; Diatrizoate; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2012
[Positron emission tomography with 18F-FDG compared with proliferative activity of tumor cells in different subtypes of non-Hodgkin lymphoma]. Voprosy onkologii, 2011, Volume: 57, Issue:6 Topics: Adult; Aged; Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Linear Models; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals	2011
18F-FDG avid in uterine leiomyoma: a case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95, Issue:2 Topics: Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leiomyoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2012
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. International journal of radiation oncology, biology, physics, 2012, Aug-01, Volume: 83, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult	2012
Peritoneal lymphomatosis found on 18F-FDG PET/CT. European journal of haematology, 2012, Volume: 89, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma. Nuclear medicine communications, 2012, Volume: 33, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Young Adult	2012
Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2013
Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT. Endocrine, 2013, Volume: 43, Issue:1 Topics: Biopsy, Fine-Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed	2013
Response assessment in lymphoma: time to lower the bar? Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, Emission-Computed; Tomography, X-Ray Computed	2013
Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2013
Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment. Leukemia & lymphoma, 2013, Volume: 54, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult	2013
The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT. Nuclear medicine communications, 2013, Volume: 34, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Child; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2013
Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:5 Topics: Aged, 80 and over; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2013
18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. International journal of hematology, 2013, Volume: 97, Issue:1 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastroscopy; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2013
SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma. PloS one, 2012, Volume: 7, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult	2012
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT. Revista espanola de medicina nuclear e imagen molecular, 2013, Volume: 32, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed	2013
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
The role of FDG-PET scanning in assessing lymphoma in 2012. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2013
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques. Journal of radiology case reports, 2012, Volume: 6, Issue:12 Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mammography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary	2012
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2002
Assessment of Lymphoma Therapy Using (18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Thyroid nodule mimicking cervical adenopathy on FDG positron emission tomographic imaging. Clinical nuclear medicine, 2002, Volume: 27, Issue:9 Topics: Adult; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Radiography; Radiopharmaceuticals; Thyroid Nodule; Tomography, Emission-Computed	2002
[(18)F]FDG in childhood lymphoma: clinical utility and impact on management. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:9 Topics: Adult; Age Factors; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisolone; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Vincristine	2002
Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma. Clinical nuclear medicine, 2002, Volume: 27, Issue:11 Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting	2002
Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003, May-15, Volume: 101, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Positron emission tomography in the management of lymphomas. Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:5 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed	2002
[FDG-PET on the day after first chemotherapy in malignant lymphoma]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:14 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Drug Monitoring; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2002
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma. Acta medica Austriaca, 2003, Volume: 30, Issue:2 Topics: Adolescent; Adult; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed	2003
Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clinical lymphoma, 2003, Volume: 4, Issue:1 Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma. Clinical lymphoma, 2003, Volume: 4, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Early restaging positron emission tomography with 18F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true? Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Treatment Outcome	2003
[Evaluation of lesions of malignant lymphoma using histograms of regional SUV]. Kaku igaku. The Japanese journal of nuclear medicine, 2003, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed	2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:3 Topics: Adult; Aged; Bone and Bones; Cell Division; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Kidney; Liver; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder	2003
FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2 Topics: Adolescent; Adult; Aged; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, Emission-Computed	2003
Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Axilla; Extravasation of Diagnostic and Therapeutic Materials; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Pelvic anatomic localization using ureteral activity on FDG positron emission tomography. Clinical nuclear medicine, 2003, Volume: 28, Issue:10 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Ilium; Image Enhancement; Lymphoma, Non-Hodgkin; Pelvis; Peritoneum; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed; Ureter	2003
Skeletal muscle uptake detected on FDG PET 48 hours after exertion. Clinical nuclear medicine, 2003, Volume: 28, Issue:10 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muscle, Skeletal; Physical Exertion; Radiopharmaceuticals; Shoulder; Tomography, Emission-Computed	2003
PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Archives of dermatological research, 2003, Volume: 295, Issue:7 Topics: Aged; Beta Particles; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed	2003
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. British journal of haematology, 2003, Volume: 123, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine	2003
Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases. Clinical nuclear medicine, 2003, Volume: 28, Issue:12 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting	2003
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2003
[18FDG PET in the management of malignant lymphoma]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2003, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	2003
FDG PET utility in paraneoplastic sweet syndrome. Clinical nuclear medicine, 2004, Volume: 29, Issue:2 Topics: Adult; Arthralgia; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Paraneoplastic Syndromes; Radiopharmaceuticals; Sweet Syndrome; Tomography, Emission-Computed	2004
PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma. Leukemia & lymphoma, 2003, Volume: 44, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Peripheral Blood Stem Cell Transplantation; Radiopharmaceuticals; Thymus Hyperplasia; Tomography, Emission-Computed; Transplantation, Autologous	2003
[The clinical application of 18F-fluorodeoxyglucose coincidence imaging in lymphoma]. Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Angiography; Male; Middle Aged; Phantoms, Imaging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2004
Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neck; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed	2004
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology, 2004, Volume: 232, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia. Clinical nuclear medicine, 2004, Volume: 29, Issue:9 Topics: Aged; Cytomegalovirus Infections; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Viral; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2004
18F-FDG PET in children with lymphomas. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:1 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2005
18F-FDG PET early after radiotherapy in lymphoma patients. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:5 Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2004
Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin. Nuclear medicine, 2005, Volume: 44, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. British journal of haematology, 2005, Volume: 128, Issue:6 Topics: Adult; Biopsy; Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Transplantation, Homologous	2005
18F-FDG PET in malignant lymphoma: significance of positive findings. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:7 Topics: Adolescent; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome	2005
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21 Topics: Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2005
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2005
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis	2005
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2006
A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neck; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Thyroid Neoplasms; Vincristine	2005
Unilateral testicular relapse of abdominal non-Hodgkin lymphoma detected by FDG-PET. Pediatric radiology, 2006, Volume: 36, Issue:3 Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Radiopharmaceuticals; Testis; Tomography, Emission-Computed	2006
Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World journal of gastroenterology, 2005, Dec-14, Volume: 11, Issue:46 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2005
Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma. Annals of nuclear medicine, 2005, Volume: 19, Issue:8 Topics: Aged; Empyema, Pleural; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Treatment Outcome	2005
Scintigraphic appearance of "linitis plastica" in a patient with gastric non-Hodgkin's lymphoma on 18F-FDG imaging. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:5 Topics: Adult; Fluorodeoxyglucose F18; Humans; Linitis Plastica; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2006
A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response. Annals of nuclear medicine, 2006, Volume: 20, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine	2006
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatric radiology, 2006, Volume: 36, Issue:6 Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2006
Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma. The British journal of radiology, 2006, Volume: 79, Issue:941 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
Multiagency effort to focus on PET as biomarker. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:4 Topics: Biomarkers, Tumor; Cooperative Behavior; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; United States; United States Dept. of Health and Human Services	2006
Detection of widespread neurolymphomatosis with 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:8 Topics: Adult; Cranial Nerve Diseases; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Diseases; Whole Body Imaging	2006
(18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies. Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2006
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer, 2006, Jul-01, Volume: 107, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone marrow transplantation, 2006, Volume: 38, Issue:3 Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2006
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:5 Topics: Adolescent; Child; Child, Preschool; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity	2006
Deep venous thrombosis on F-18 FDG PET/CT imaging. Clinical nuclear medicine, 2006, Volume: 31, Issue:7 Topics: Aged; Femoral Vein; Fluorodeoxyglucose F18; Humans; Iliac Vein; Lymphoma, Non-Hodgkin; Male; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thrombophlebitis; Tomography, X-Ray Computed	2006
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Nuclear medicine review. Central & Eastern Europe, 2006, Volume: 9, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Stomach Neoplasms; Time Factors	2006
Late clinically silent perforation of intestinal non-Hodgkin's lymphoma. Clinical lymphoma & myeloma, 2006, Volume: 6, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Perforation; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:7 Topics: Child, Preschool; Extremities; Fatal Outcome; Female; Fluorodeoxyglucose F18; Groin; Hand; Humans; Infant; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Remission Induction; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Survival Rate; Thigh; Tomography, X-Ray Computed; Treatment Outcome	2006
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Annals of hematology, 2006, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed	2006
Diagnosis of neurolymphomatosis with FDG PET. Neurology, 2006, Aug-22, Volume: 67, Issue:4 Topics: Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2006
Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology, 2006, Volume: 113, Issue:12 Topics: Adult; Aged; Conjunctival Neoplasms; Eye Neoplasms; Eyelid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiography, Abdominal; Sclerosis; Tomography, X-Ray Computed	2006
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. British journal of haematology, 2006, Volume: 135, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leukemia & lymphoma, 2006, Volume: 47, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2006
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma. The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:10 Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography	2006
Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2007, Volume: 45, Issue:1 Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2007
Revised response criteria for malignant lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Clinical Trials as Topic; Endpoint Determination; Flow Cytometry; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Terminology as Topic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
FDG-PET lymphoma demonstration project invitational workshop. Academic radiology, 2007, Volume: 14, Issue:3 Topics: Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Quality Assurance, Health Care; Reproducibility of Results	2007
Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET. Clinical nuclear medicine, 2007, Volume: 32, Issue:3 Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Osteomyelitis; Radiopharmaceuticals; Recurrence; Tibia; Tomography, Emission-Computed	2007
Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed	2007
Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma. European journal of haematology, 2007, Volume: 79, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine	2007
Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma. Clinical nuclear medicine, 2007, Volume: 32, Issue:7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Sarcoidosis; Spleen; Tomography, X-Ray Computed; Vincristine	2007
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization c Cancer, 2007, Aug-01, Volume: 110, Issue:3 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; World Health Organization	2007
[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report. Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Treatment Outcome; Uterine Neoplasms; Vincristine	2007
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. European journal of radiology, 2008, Volume: 66, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging	2008
Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT. Clinical nuclear medicine, 2007, Volume: 32, Issue:8 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sciatic Neuropathy; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging	2007
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria. Leukemia & lymphoma, 2007, Volume: 48, Issue:8 Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2007
Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18)F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Analysis; Tomography, Emission-Computed	2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nuclear medicine communications, 2007, Volume: 28, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab	2007
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:10 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals	2007
Multimodality imaging of direct ureteric involvement in non-Hodgkin's lymphoma using PET/CT, CT urography and antegrade CT pyelography. The British journal of radiology, 2007, Volume: 80, Issue:959 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ureteral Neoplasms; Urography	2007
PET versus PET-CT in patient with suspicion of non-Hodgkin lymphoma recurrence. Clinical nuclear medicine, 2007, Volume: 32, Issue:12 Topics: Aneurysm, Infected; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2007
Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET. Archives of medical research, 2008, Volume: 39, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma. Clinical nuclear medicine, 2008, Volume: 33, Issue:2 Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals	2008
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Europe; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Vincristine	2008
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2008
Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT. Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:1 Topics: Aorta, Abdominal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Elucidation of acute renal failure due to recurrent non-Hodgkin lymphoma by F-18 FDG PET/CT. Clinical nuclear medicine, 2008, Volume: 33, Issue:3 Topics: Acute Kidney Injury; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging	2008
Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Spleen; Splenectomy	2008
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation. Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Autologous	2008
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. La Radiologia medica, 2008, Volume: 113, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
Predicting malignancy grade with PET in non-Hodgkin's lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:10 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Predictive Value of Tests; Tomography, Emission-Computed	1995
Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood, 1995, Nov-01, Volume: 86, Issue:9 Topics: Adult; Aged; Cell Division; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Tomography, Emission-Computed	1995
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. European journal of nuclear medicine, 1995, Volume: 22, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water	1995
FDG-PET for predicting the prognosis of malignant lymphoma. Annals of nuclear medicine, 1994, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed	1994
FDG-PET for the evaluation of tumor viability after anticancer therapy. Annals of nuclear medicine, 1994, Volume: 8, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Radiotherapy, High-Energy; Tomography, Emission-Computed	1994
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics : a review publication of the Radiological Society of North America, Inc, 1993, Volume: 13, Issue:5 Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed	1993
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography. European journal of nuclear medicine, 1993, Volume: 20, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine	1993
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Hormone and metabolic research. Supplement series, 1993, Volume: 27 Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed	1993
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:10 Topics: Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Remission Induction; Tomography, Emission-Computed, Single-Photon	1993
Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha. Annals of hematology, 1996, Volume: 72, Issue:2 Topics: Acidosis, Lactic; Aged; Deoxyglucose; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gastrointestinal Hemorrhage; Humans; Hypoglycemia; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Pelvic Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha	1996
The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:1 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1996
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3 Topics: Adolescent; Adult; Aged; Algorithms; Biopsy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Health Care Costs; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Tomography, Emission-Computed	1997
Primary muscle lymphoma: clinical and imaging findings. Radiology, 1997, Volume: 203, Issue:1 Topics: Adolescent; Adult; Aged; Bone and Bones; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]. Der Radiologe, 1997, Volume: 37, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome	1997
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology, 1997, Volume: 203, Issue:3 Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1997
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma]. Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:7 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology, 1998, Volume: 206, Issue:2 Topics: Adult; Biopsy; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed	1998
Usefulness of FDG-PET in diagnosing primary lymphoma of the liver. International journal of hematology, 1997, Volume: 66, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	1997
Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study. American journal of clinical oncology, 1998, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Agents; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood, 1998, Jun-15, Volume: 91, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	1998
[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998, Volume: 168, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma. Acta radiologica. Supplementum, 1998, Volume: 417 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart. Circulation, 1998, Jun-30, Volume: 97, Issue:25 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed	1998
F-18-FDG uptake in tuberculosis. Clinical nuclear medicine, 1998, Volume: 23, Issue:11 Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paget's Disease, Mammary; Radionuclide Imaging; Radiopharmaceuticals; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary	1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nuclear medicine communications, 1998, Volume: 19, Issue:11 Topics: Adolescent; Adult; Aged; Blood Glucose; Body Surface Area; Body Weight; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. European journal of nuclear medicine, 1999, Volume: 26, Issue:1 Topics: Adolescent; Adult; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nuclear medicine communications, 1999, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Digestive System; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 1999, Jul-15, Volume: 94, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diagnosis, Differential; Disease-Free Survival; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagnostic cytopathology, 1999, Volume: 21, Issue:1 Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Tomography, Emission-Computed	1999
Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. British journal of cancer, 1999, Volume: 80, Issue:3-4 Topics: Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lipolysis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed	1999
[Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:8 Topics: Abdominal Neoplasms; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Granulocytes; Humans; Lymphoma, Non-Hodgkin; Macrophages; Male; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11 Suppl 1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Positron emission tomography for detection and staging of malignant lymphoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2000, Volume: 156 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
FDG positron emission tomography in lymphoma. Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel, 2000 Topics: Blue Cross Blue Shield Insurance Plans; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration	2000
Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy: evaluation with FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed	2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 2000, Volume: 85, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Treatment Outcome	2000
The impact of FDG positron emission tomography imaging on the management of lymphomas. The British journal of radiology, 2000, Volume: 73, Issue:869 Topics: Adolescent; Adult; Aged; Contrast Media; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma. Clinical nuclear medicine, 2000, Volume: 25, Issue:7 Topics: Adult; Bone Marrow Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed	2000
Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Clinical nuclear medicine, 2000, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2000
Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:8 Topics: Abdomen; Adult; Blood Glucose; Butylscopolammonium Bromide; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Lymphoma, Non-Hodgkin; Male; Parasympatholytics; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed	2000
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Survival Analysis; Tomography, Emission-Computed	2001
[Value of positron emission tomography in treatment of lymphoma patients]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:3 Topics: Blood Glucose; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Treatment Outcome	2001
F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma. Clinical nuclear medicine, 2001, Volume: 26, Issue:4 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2001
False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma. Clinical nuclear medicine, 2001, Volume: 26, Issue:5 Topics: Adolescent; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Diseases; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gamma Cameras; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
FDG PET imaging in patients with lymphoma: a clinical perspective. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT. Leukemia & lymphoma, 2000, Volume: 39, Issue:5-6 Topics: Adult; Age Factors; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2000
Similar pelvic abnormalities on FDG positron emission tomography of different origins. Clinical nuclear medicine, 2001, Volume: 26, Issue:6 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin. Nuclear medicine, 2001, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	2001
18F-Fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: the only sensitive method of imaging. The American journal of gastroenterology, 2001, Volume: 96, Issue:8 Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Pulmonary intravascular lymphoma complicated with Pneumocystis carinii pneumonia: a case report. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:7 Topics: Aged; Dementia; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Pneumocystis; Radionuclide Imaging; Vascular Neoplasms	2001
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL). Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:4 Topics: Adult; Aged; Bone Marrow; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed	2001
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography. Clinical lymphoma, 2001, Volume: 1, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Vincristine	2001
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy. Clinical nuclear medicine, 2002, Volume: 27, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Parotid Neoplasms; Radiopharmaceuticals; Rituximab; Sjogren's Syndrome; Tomography, Emission-Computed	2002
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. British journal of haematology, 2001, Volume: 115, Issue:4 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Tomography, Emission-Computed	2001
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2002
Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
FDG PET in the management of lymphoma: a clinical perspective. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
[Diagnosis of energy metabolism in ENT tumors--a PET study]. HNO, 1992, Volume: 40, Issue:6 Topics: Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Hemangiopericytoma; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate; Tomography, Emission-Computed	1992
Suitability of rodent tumor models for experimental PET with L-[1-11C]tyrosine and 2-[18F]fluoro-2-deoxy-D-glucose. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Volume: 18, Issue:5 Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Proteins; Rats; Rats, Inbred Strains; Tissue Distribution; Tomography, Emission-Computed; Tyrosine	1991
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed	1991
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:6 Topics: Adult; Aged; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methionine; Middle Aged; Tomography, Emission-Computed	1991
Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987, Volume: 28, Issue:3 Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Drug Evaluation; Female; Fluorine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms	1987